Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Clav Regulatory News (JCH)

Share Price Information for Jpmorgan Clav (JCH)

Share Price is delayed by 15 minutes
Get Live Data
916.00    2.00 (0.22%)
Bid:
916.00
Ask:
920.00
Spread: 4.00 (0.437%)
Market Cap: £498.40m
JCH Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Clav Share Chart

Directorate change

25 Mar 2026 07:00

RNS Number : 9770X
JPMorgan Claverhouse IT PLC
25 March 2026
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

 JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

 

 

APPOINTMENT OF DIRECTOR

 

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

Information disclosed in accordance with the UK Listing Rules 6.4.6 R (1) and 6.4.8 R (1)

 

The Board of JPMorgan Claverhouse Investment Trust plc (the 'Company') is pleased to announce the appointment of Mr. Graham Oldroyd as a Non-Executive Director of the Company with effect from the conclusion of the Annual General Meeting to be held on 7th May 2026. On appointment, Mr Oldroyd will serve as Senior Independent Director (SID) and Chairman of the Management Engagement Committee.

 

Mr. Oldroyd is an experienced Director with strong international leadership profile in private equity and industry, combining wide sector knowledge and in-depth expertise in strategic investment, mergers and acquisitions, joint ventures and business development.

 

Mr. Oldroyd is currently a Non-Executive Director of Senior plc, Deputy Chairman of Videndum plc and Chairman of The Global Smaller Companies Trust PLC.

 

Mr. Oldroyd does not own any shares of the Company.

 

The Company discloses this information pursuant to the Financial Conduct Authority's UK Listing Rules 6.4.6 R (1) and 6.4.8 R (1). No further information is to be disclosed pursuant to UK Listing Rules 6.4.8 R (2) to 6.4.8 R (6) in respect of Mr. Oldroyd.

 

 

25th March 2026

 

 

For further information, please contact:

Anmol Dhillon

JPMorgan Funds Limited, Company Secretary

0800 20 40 20 (or +44 1268 44 44 70)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABCGDXDBDDGLS
Date   Source Headline
30th Apr 20268:24 amRNS-RQuotedData's In The HotSeat
29th Apr 202611:06 amRNSNet Asset Value(s)
28th Apr 202611:04 amRNSNet Asset Value(s)
27th Apr 202612:03 pmRNSGearing Announcement
27th Apr 202611:19 amRNSNet Asset Value(s)
24th Apr 202611:19 amRNSNet Asset Value(s)
23rd Apr 202611:01 amRNSNet Asset Value(s)
22nd Apr 202611:14 amRNSNet Asset Value(s)
21st Apr 202611:02 amRNSNet Asset Value(s)
20th Apr 202611:40 amRNSGearing announcement
20th Apr 202611:11 amRNSNet Asset Value(s)
17th Apr 202610:40 amRNSNet Asset Value(s)
16th Apr 20266:00 pmRNSChanges in FTSE UK Index Series
16th Apr 202610:34 amRNSNet Asset Value(s)
16th Apr 20267:00 amRNS-RKepler Trust Intelligence: New Research
15th Apr 202611:21 amRNSNet Asset Value(s)
14th Apr 20263:17 pmRNSTen Largest Investments
14th Apr 202610:54 amRNSNet Asset Value(s)
13th Apr 202612:07 pmRNSGearing announcement
13th Apr 202611:12 amRNSNet Asset Value(s)
10th Apr 202611:07 amRNSNet Asset Value(s)
9th Apr 202611:06 amRNSNet Asset Value(s)
8th Apr 202610:27 amRNSNet Asset Value(s)
7th Apr 20265:35 pmRNSNOTIFICATION OF CROSS HOLDING
7th Apr 202612:24 pmRNSGearing Announcement
7th Apr 202611:38 amRNSNet Asset Value(s)
2nd Apr 202611:19 amRNSNet Asset Value(s)
1st Apr 202611:48 amRNSNet Asset Value(s)
1st Apr 202610:10 amRNSTotal Voting Rights
31st Mar 20264:52 pmRNSTransaction in Own Shares
31st Mar 202611:22 amRNSNet Asset Value(s)
30th Mar 20265:14 pmRNSTransaction in Own Shares
30th Mar 202612:06 pmRNSGearing Announcement
30th Mar 202611:30 amRNSNet Asset Value(s)
27th Mar 202611:26 amRNSNet Asset Value(s)
26th Mar 202611:17 amRNSNet Asset Value(s)
25th Mar 202610:56 amRNSNet Asset Value(s)
25th Mar 20267:00 amRNSDirectorate change
25th Mar 20267:00 amRNSDividend Declaration
25th Mar 20267:00 amRNSFinal Results
24th Mar 202611:29 amRNSNet Asset Value(s)
23rd Mar 20261:38 pmRNSGearing Announcement
23rd Mar 202610:58 amRNSNet Asset Value(s)
20th Mar 202611:28 amRNSNet Asset Value(s)
19th Mar 202610:46 amRNSNet Asset Value(s)
18th Mar 202611:02 amRNSNet Asset Value(s)
17th Mar 202611:12 amRNSNet Asset Value(s)
16th Mar 202611:34 amRNSGearing Announcement
16th Mar 202611:34 amRNSGearing Announcement
16th Mar 202611:18 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.